Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for knee osteoarthritis across BMI categories
RBR-6n8gkvpPhase 3Recruiting
- Sponsor
- Universidade Federal Fluminense
- Start
- Jun 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich plasma in knee osteoarthritis (OA) (4 arms), sponsored by Universidade Federal Fluminense. Started Jun 2026; status: recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on RBR-6n8gkvp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6n8gkvp.